title: Mortality by treatment in patients ≥80 years of age with gastroesophageal cancer seen in a 20-year period at a single medical center.
abstract: The treatment approach to patients 80 years of age and older with gastroesophageal cancer at Baylor Scott and White in Temple, Texas, has historically favored conservative measures in the form of palliation and observation. To evaluate this trend in practice, the administered treatments and subsequent patient outcomes of this group were retrospectively reviewed. The study group included all patients 80 years of age and older with a diagnosis of gastroesophageal cancer seen at our facility between 1991 and 2010. Of the 117 cases, 49% received none of the available treatment modalities. The median overall survival (OS) of patients who received treatment, however, was significantly longer than the OS of those who did not, regardless of modality. Specifically, surgical intervention offered an almost double median OS compared with no therapy (6.8 vs. 3.9 months, respectively; P = 0.02); chemotherapy, an almost 4-fold OS benefit (14.8 vs. 3.9 months; P = 0.03); and radiation therapy, a >3-fold OS benefit (11.1 vs. 3.5 months; P = 0.04). These results further substantiate chronological age as an inaccurate predictor of treatment benefit, and age alone should not dictate the administration or withholding of available treatment options.
authors.affiliation: Division of Hematology and Oncology (Barnett, Wong), the Department of Internal Medicine (Mason), and the Office of Biostatistics (Munoz Maldonado), Baylor Scott & White Health, Scott & White Memorial Hospital, Temple, Texas.
authors.forename: Tara
authors.initials: T
authors.lastname: Barnett
authors.affiliation: Division of Hematology and Oncology (Barnett, Wong), the Department of Internal Medicine (Mason), and the Office of Biostatistics (Munoz Maldonado), Baylor Scott & White Health, Scott & White Memorial Hospital, Temple, Texas.
authors.forename: James
authors.initials: J
authors.lastname: Mason
authors.affiliation: Division of Hematology and Oncology (Barnett, Wong), the Department of Internal Medicine (Mason), and the Office of Biostatistics (Munoz Maldonado), Baylor Scott & White Health, Scott & White Memorial Hospital, Temple, Texas.
authors.forename: Yolanda Munoz
authors.initials: YM
authors.lastname: Maldonado
authors.affiliation: Division of Hematology and Oncology (Barnett, Wong), the Department of Internal Medicine (Mason), and the Office of Biostatistics (Munoz Maldonado), Baylor Scott & White Health, Scott & White Memorial Hospital, Temple, Texas.
authors.forename: Lucas
authors.initials: L
authors.lastname: Wong